SPPI logo

Spectrum Pharmaceuticals (SPPI) Revenue

Annual Revenue

$10.11 M
NaN%

December 31, 2022

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

SPPI Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$72.48 M
SPPI annual revenue is currently -86.05% lower than the consensus analysts' forecast

High & Low

All-time High

$267.71 M
SPPI annual revenue is currently -96.22% below its historical high of $267.71 million

3-Year Low

$10.11 M
SPPI annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
SPPI previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
SPPI next annual earnings announcement has not yet been scheduled

OtherSPPIprofitabilitymetrics:

Annual EPS

-$0.41
SPPI annual earnings per share is -$0.41

Annual Net Income

-$75.40 M
SPPI annual net profit is -$75.40 million

Annual Operating Profit

-$72.70 M
SPPI annual operating income is -$72.70 million

Annual Gross Profit

$8.32 M
SPPI annual gross profit is $8.32 million

Quarterly Revenue

$15.62 M
+$5.50 M+54.39%

March 31, 2023

Summary

Performance

3-Month Change

+54.39%

1-Year Change

-

3-Year Change

-

5-Year Change

-

SPPI Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$17.18 M
SPPI quarterly revenue is currently -9.11% lower than the consensus analysts' forecast

High & Low

All-time High

$70.10 M
SPPI quarterly revenue is currently -77.73% below its historical high of $70.10 million

3-Year Low

$10.11 M
SPPI quarterly revenue is currently +54.39% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
SPPI previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
SPPI next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$14.55 M
SPPI quarterly gross profit is $14.55 million

Quarterly Operating Profit

-$4.87 M
SPPI quarterly operating income is -$4.87 million

Quarterly Net Income

-$5.01 M
SPPI quarterly net profit is -$5.01 million

Quarterly EPS

-$0.02
SPPI quarterly earnings per share is -$0.02

TTM Revenue

$25.73 M
+$15.62 M+154.39%

March 31, 2023

Summary

Performance

3-Month Change

+154.39%

1-Year Change

-

3-Year Change

-

5-Year Change

-

SPPI TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$42.91 M
SPPI TTM revenue is currently -40.04% lower than the consensus analysts' forecast

High & Low

All-time High

$267.71 M
SPPI TTM revenue is currently -90.39% below its historical high of $267.71 million

3-Year Low

$10.11 M
SPPI TTM revenue is currently +154.39% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
SPPI previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
SPPI next earnings announcement has not yet been scheduled

OtherSPPIprofitabilitymetrics:

TTM Gross Profit

$14.55 M
SPPI TTM gross profit is $14.55 million

TTM Operating Profit

-$63.50 M
SPPI TTM operating income is -$63.50 million

TTM Net Income

-$64.97 M
SPPI TTM net profit is -$64.97 million

TTM EPS

-$0.36
SPPI TTM earnings per share is -$0.36

SPPI Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

SPPI Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high-35.2%at high-60.7%
5 y5-yearat highat lowat high-35.2%at high-60.7%
alltimeall time-96.2%-100.0%-77.7%-739.1%-90.4%-100.4%

Spectrum Pharmaceuticals Revenue History

DateAnnualQuarterlyTTM
Mar 2023
-
$15.62 M(+54.4%)
$25.73 M(+154.4%)
Dec 2022
$10.11 M(-93.1%)
$10.11 M(-110.1%)
$10.11 M(>+9900.0%)
Dec 2017
-
-$99.80 M(-374.2%)
$0.00(-100.0%)
Sep 2017
-
$36.40 M(+6.1%)
$135.03 M(+2.3%)
Jun 2017
-
$34.30 M(+17.9%)
$132.03 M(+0.3%)
Mar 2017
-
$29.10 M(-17.4%)
$131.68 M(-10.1%)
Dec 2016
$146.44 M(-9.9%)
$35.24 M(+5.5%)
$146.44 M(-9.3%)
Sep 2016
-
$33.39 M(-1.6%)
$161.54 M(+3.0%)
Jun 2016
-
$33.95 M(-22.6%)
$156.77 M(-6.6%)
Mar 2016
-
$43.87 M(-12.8%)
$167.81 M(+3.2%)
Dec 2015
$162.56 M(-13.0%)
$50.33 M(+75.8%)
$162.56 M(-0.9%)
Sep 2015
-
$28.63 M(-36.4%)
$164.09 M(-10.6%)
Jun 2015
-
$44.98 M(+16.5%)
$183.45 M(-1.0%)
Mar 2015
-
$38.62 M(-25.5%)
$185.32 M(-0.8%)
Dec 2014
$186.83 M(+19.9%)
$51.86 M(+8.1%)
$186.83 M(+5.9%)
Sep 2014
-
$47.99 M(+2.4%)
$176.49 M(+3.2%)
Jun 2014
-
$46.85 M(+16.8%)
$170.93 M(+8.7%)
Mar 2014
-
$40.12 M(-3.4%)
$157.31 M(+0.9%)
Dec 2013
$155.85 M(-41.8%)
$41.52 M(-2.2%)
$155.85 M(-15.5%)
Sep 2013
-
$42.44 M(+27.7%)
$184.44 M(-12.6%)
Jun 2013
-
$33.23 M(-14.1%)
$211.04 M(-14.4%)
Mar 2013
-
$38.67 M(-44.8%)
$246.51 M(-7.9%)
Dec 2012
$267.71 M(+38.7%)
$70.10 M(+1.5%)
$267.71 M(+6.8%)
Sep 2012
-
$69.04 M(+0.5%)
$250.58 M(+7.7%)
Jun 2012
-
$68.70 M(+14.8%)
$232.56 M(+11.2%)
Mar 2012
-
$59.86 M(+13.0%)
$209.22 M(+8.4%)
Dec 2011
$192.96 M(+160.4%)
$52.98 M(+3.8%)
$192.96 M(+10.9%)
Sep 2011
-
$51.02 M(+12.5%)
$173.93 M(+24.6%)
Jun 2011
-
$45.36 M(+4.0%)
$139.64 M(+31.0%)
Mar 2011
-
$43.60 M(+28.4%)
$106.62 M(+43.9%)
Dec 2010
$74.11 M(+94.9%)
$33.95 M(+102.8%)
$74.11 M(+51.9%)
Sep 2010
-
$16.73 M(+35.6%)
$48.79 M(+24.6%)
Jun 2010
-
$12.34 M(+11.3%)
$39.15 M(+12.0%)
Mar 2010
-
$11.09 M(+28.6%)
$34.95 M(-8.1%)
Dec 2009
$38.02 M(+32.4%)
$8.62 M(+21.4%)
$38.02 M(+1.5%)
Sep 2009
-
$7.10 M(-12.8%)
$37.45 M(+23.4%)
Jun 2009
-
$8.14 M(-42.5%)
$30.35 M(-29.2%)
Mar 2009
-
$14.16 M(+76.0%)
$42.89 M(+49.3%)
Dec 2008
$28.73 M(+274.4%)
$8.05 M(-61.1%)
$28.73 M(+19.8%)
Jun 2008
-
$20.68 M(>+9900.0%)
$23.97 M(+212.5%)
DateAnnualQuarterlyTTM
Dec 2007
$7.67 M(+35.2%)
$47.00 K(-98.6%)
$7.67 M(-41.9%)
Sep 2007
-
$3.25 M(-19.4%)
$13.21 M(+31.4%)
Jun 2007
-
$4.03 M(+1075.5%)
$10.05 M(+67.0%)
Mar 2007
-
$343.00 K(-93.9%)
$6.02 M(+6.0%)
Dec 2006
$5.67 M(+883.2%)
$5.58 M(+5966.3%)
$5.67 M(+2215.5%)
Sep 2006
-
$92.00 K(-39.9%)
$245.00 K(-57.5%)
Dec 2005
$577.00 K(+123.6%)
$153.00 K(-16.8%)
$577.00 K(-5.3%)
Sep 2005
-
$184.00 K(-23.3%)
$609.00 K(+43.3%)
Jun 2005
-
$240.00 K(+29.7%)
$425.00 K(+64.7%)
Dec 2004
$258.00 K(-74.2%)
$185.00 K(+153.4%)
$258.00 K(-76.0%)
Jun 2004
-
$73.00 K(-92.7%)
$1.07 M(-6.8%)
Dec 2003
$1.00 M(-57.8%)
-
-
Sep 2003
-
$1.00 M(+559.2%)
$1.15 M(-51.4%)
Dec 2002
$2.37 M(+5668.9%)
$151.70 K(-92.4%)
$2.37 M(+5.7%)
Sep 2002
-
$2.01 M(+951.5%)
$2.24 M(+820.7%)
Jun 2002
-
$191.00 K(+855.0%)
$243.70 K(+299.5%)
Mar 2002
-
$20.00 K(-18.0%)
$61.00 K(+48.8%)
Dec 2001
$41.10 K(>+9900.0%)
$24.40 K(+194.0%)
$41.00 K(+147.0%)
Sep 2001
-
$8300.00(0.0%)
$16.60 K(+100.0%)
Jun 2001
-
$8300.00(>+9900.0%)
$8300.00(>+9900.0%)
Mar 2001
-
$0.00(0.0%)
$0.00(-100.0%)
Sep 2000
-
$0.00(0.0%)
-$100.00 K(<-9900.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(-100.0%)
$0.00(0.0%)
Dec 1999
$0.00(0.0%)
-$100.00 K(-200.0%)
$0.00(0.0%)
Sep 1999
-
$100.00 K(>+9900.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 1999
-
$0.00(-100.0%)
$100.00 K(-50.0%)
Dec 1998
$0.00(0.0%)
-$100.00 K(-200.0%)
$200.00 K(0.0%)
Sep 1998
-
$100.00 K(0.0%)
$200.00 K(0.0%)
Jun 1998
-
$100.00 K(0.0%)
$200.00 K(0.0%)
Mar 1998
-
$100.00 K(-200.0%)
$200.00 K(0.0%)
Dec 1997
$0.00(-100.0%)
-$100.00 K(-200.0%)
$200.00 K(-33.3%)
Sep 1997
-
$100.00 K(0.0%)
$300.00 K(0.0%)
Jun 1997
-
$100.00 K(0.0%)
$300.00 K(0.0%)
Mar 1997
-
$100.00 K(0.0%)
$300.00 K(0.0%)
Dec 1996
$100.00 K
-
-
Sep 1996
-
$100.00 K(0.0%)
$300.00 K(+50.0%)
Jun 1996
-
$100.00 K(0.0%)
$200.00 K(+100.0%)
Mar 1996
-
$100.00 K
$100.00 K

FAQ

  • What is Spectrum Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for Spectrum Pharmaceuticals?
  • What is Spectrum Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for Spectrum Pharmaceuticals?
  • What is Spectrum Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for Spectrum Pharmaceuticals?

What is Spectrum Pharmaceuticals annual revenue?

The current annual revenue of SPPI is $10.11 M

What is the all time high annual revenue for Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals all-time high annual revenue is $267.71 M

What is Spectrum Pharmaceuticals quarterly revenue?

The current quarterly revenue of SPPI is $15.62 M

What is the all time high quarterly revenue for Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals all-time high quarterly revenue is $70.10 M

What is Spectrum Pharmaceuticals TTM revenue?

The current TTM revenue of SPPI is $25.73 M

What is the all time high TTM revenue for Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals all-time high TTM revenue is $267.71 M